Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ferricrocin-iron
- Development stage
- Unknown
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Ferricrocin-iron is an experimental small molecule complex consisting of the siderophore ferricrocin chelated with iron. Siderophores like ferricrocin are natural iron-chelating compounds produced by microorganisms to facilitate iron uptake in low-iron environments. Ferricrocin binds Fe(III) ions tightly, forming a stable complex that can be used for research into microbial iron transport and metabolism. There is no evidence of clinical use or approval for therapeutic indications in humans[1][3]. Its mechanism involves high-affinity binding and transport of Fe(III), but it is not developed as a pharmaceutical product.
- Other names
- FERRICROCIN-IRON
02
Targets
Fe3+ (Ferric iron)
Beyond the preview
Go deeper on ferricrocin-iron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ferricrocin-iron.